A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-naïve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms
出版年份 2023 全文链接
标题
A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-naïve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms
作者
关键词
-
出版物
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-30
DOI
10.1038/s41386-023-01760-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of a six-month yoga intervention on the immune-inflammatory pathway in antipsychotic-stabilized schizophrenia patients: A randomized controlled trial
- (2023) Thrinath Mullapudi et al. Asian Journal of Psychiatry
- Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment
- (2021) Marcella Reale et al. Frontiers in Psychiatry
- The impact of study design on schizophrenia incidence estimates: A systematic review of Northern European studies 2008–2019
- (2021) Simon J. Hogerzeil et al. SCHIZOPHRENIA RESEARCH
- Interrelationships Between Oxidative Stress, Cytokines, and Psychotic Symptoms and Executive Functions in Patients With Chronic Schizophrenia
- (2021) Zhi Wei Wu et al. PSYCHOSOMATIC MEDICINE
- Neuroprotective effect of combined use of nicotine and celecoxib by inhibiting neuroinflammation in ischemic rats
- (2021) Jinyu Gou et al. BRAIN RESEARCH BULLETIN
- Neuro-Immune Aspects of Schizophrenia with Severe Negative Symptoms: New Diagnostic Markers of Disease Phenotype
- (2021) I.K. Malashenkova et al. Sovremennye Tehnologii v Medicine
- The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia
- (2020) Pia M. Vidal et al. Frontiers in Pharmacology
- The Role of Inflammation in the Treatment of Schizophrenia
- (2020) Guillaume Fond et al. Frontiers in Psychiatry
- COX-2 gene rs689466 polymorphism is associated with increased risk of colorectal cancer among Caucasians: a meta-analysis
- (2020) Yong-Chen Zhang et al. World Journal of Surgical Oncology
- Association of the cyclooxygenase-2 1759A allele with migraine in Chinese Han individuals
- (2020) Xinying Guan et al. PLoS One
- The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation
- (2020) Ashley L. Comer et al. Frontiers in Cellular Neuroscience
- Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatment
- (2020) Carl R. Krynicki et al. BRAIN BEHAVIOR AND IMMUNITY
- Celecoxib Exerts a Therapeutic Effect Against Demyelination by Improving the Immune and Inflammatory Microenvironments
- (2020) Peipei Cao et al. Journal of Inflammation Research
- Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials
- (2019) Myeongju Cho et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- The association between schizophrenia and the immune system: Review of the evidence from unbiased ‘omic-studies’
- (2019) Hans C. van Mierlo et al. SCHIZOPHRENIA RESEARCH
- Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode
- (2019) Jolanta Zanelli et al. AMERICAN JOURNAL OF PSYCHIATRY
- Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia
- (2019) Svenja V. Trossbach et al. Translational Psychiatry
- COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
- (2019) Norbert Müller Frontiers in Psychiatry
- An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis
- (2019) N. Çakici et al. PSYCHOLOGICAL MEDICINE
- Cytokine Alterations in Schizophrenia: An Updated Review
- (2019) Sara Momtazmanesh et al. Frontiers in Psychiatry
- Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
- (2018) Norbert Müller SCHIZOPHRENIA BULLETIN
- Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
- (2017) Wei Zheng et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Immunology of Schizophrenia
- (2017) Norbert Müller NEUROIMMUNOMODULATION
- Serum IL-18 level, clinical symptoms and IL-18-607A/C polymorphism among chronic patients with schizophrenia in a Chinese Han population
- (2016) Xiang Yang Zhang et al. PSYCHONEUROENDOCRINOLOGY
- Clinical studies of neuroinflammatory mechanisms in schizophrenia
- (2016) Crystal C. Watkins et al. SCHIZOPHRENIA RESEARCH
- Second-generation antipsychotic effect on cognition in patients with schizophrenia-a meta-analysis of randomized clinical trials
- (2015) R. E. Nielsen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Schizophrenia and psychoneuroimmunology
- (2015) Barbara Sperner-Unterweger et al. CURRENT OPINION IN PSYCHIATRY
- Functional Polymorphisms inCOX-2Gene Are Correlated with the Risk of Oral Cancer
- (2015) Dong Li et al. Biomed Research International
- Intestinal PTGS2 mRNA Levels, PTGS2 Gene Polymorphisms, and Colorectal Carcinogenesis
- (2014) Lotte K. Vogel et al. PLoS One
- The −1195G allele increases the transcriptional activity of cyclooxygenase-2 gene (COX-2) in colon cancer cell lines
- (2013) Carina Pereira et al. MOLECULAR CARCINOGENESIS
- Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
- (2013) I. E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- (2012) Imran B Chaudhry et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation
- (2011) A E Moore et al. ONCOGENE
- Inhibition of Secretion of Interleukin (IL)-12/IL-23 Family Cytokines by 4-Trifluoromethyl-celecoxib Is Coupled to Degradation via the Endoplasmic Reticulum Stress Protein HERP
- (2010) Martin McLaughlin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders
- (2010) Wijnand Laan et al. JOURNAL OF CLINICAL PSYCHIATRY
- No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression
- (2010) Alessandro Serretti et al. PSYCHIATRY RESEARCH
- Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
- (2010) Norbert Müller et al. SCHIZOPHRENIA RESEARCH
- A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia
- (2009) Yechiel Levkovitz et al. JOURNAL OF CLINICAL PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now